| World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access |
| Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc |
| Journal website http://www.wjon.org |
Review
Volume 4, Number 3, June 2013, pages 129-136
Principles and Innovations in Peritoneal Surface Malignancy Treatment
Tables
| Anatomic origin |
| Intra-abdominal: gastric, colorectal, pancreatic, hepatocellular, appendiceal |
| Gynecologic: ovarian, endometrial, uterine |
| Peritoneum |
| Renal, bladder |
| Primary Tumor Histology-Those malignancies capable of spreading to involve the peritoneum are diverse and include |
| Primary peritoneal carcinomas |
| Malignant peritoneal mesothelioma |
| Metastases from a non-peritoneal primary: adenocarcinomas, sarcomas, neuroendocrine tumors, desmoplastic tumors, lymphomas |
| Pseudomyxoma Peritonei |
| 55% of such high risk patients meeting one of the below criteria will develop PC. |
| Criteria for patients found to be at greater risk of colorectal PC development [80] |
| Symptoms/signs of disease recurrence |
| Increased risk for regional malignancy recurrence |
| Rising CEA blood level |
| Prospective study’s defined criteria for patients with high risk of colorectal PC development [55] |
| Ovarian metastases |
| Emergent signs of obstruction or bleeding |
| Tumor perforation |
| Limited/resected disease on initial surgery |
| T4 lesions with adjacent organ resection en bloc |